FLSM
Frazier Life Sciences Management’s NewAmsterdam Pharma NAMS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $301M | Buy |
16,607,074
+490,656
| +3% | +$8.89M | 12.03% | 3 |
|
|
2025
Q1 | $330M | Buy |
16,116,418
+200,000
| +1% | +$4.09M | 15.08% | 1 |
|
|
2024
Q4 | $409M | Buy |
15,916,418
+3,061,224
| +24% | +$78.7M | 16.98% | 1 |
|
|
2024
Q3 | $213M | Buy |
12,855,194
+628,251
| +5% | +$10.4M | 8.55% | 2 |
|
|
2024
Q2 | $235M | Hold |
12,226,943
| – | – | 10.99% | 1 |
|
|
2024
Q1 | $289M | Buy |
12,226,943
+95,238
| +0.8% | +$2.25M | 12.2% | 1 |
|
|
2023
Q4 | $136M | Hold |
12,131,705
| – | – | 7.25% | 3 |
|
|
2023
Q3 | $112M | Buy |
12,131,705
+1,259,902
| +12% | +$11.7M | 7.45% | 4 |
|
|
2023
Q2 | $129M | Buy |
10,871,803
+1,530,252
| +16% | +$18.2M | 7.72% | 4 |
|
|
2023
Q1 | $126M | Hold |
9,341,551
| – | – | 9.09% | 2 |
|
|
2022
Q4 | $102M | Buy |
+9,341,551
| New | +$102M | 6.33% | 5 |
|